ERIN GILSON: Open Payments
NPI 1518512441 · NEWPORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$961 in 54 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $530 · 2025 $961
Food & beverage: $961
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 16 | $204 |
| ABBVIE INC. | 8 | $160 |
| Exact Sciences Corporation | 7 | $142 |
| Novo Nordisk Inc | 6 | $105 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Sumitomo Pharma America, Inc. | 1 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $34 |
| Eisai Inc. | 1 | $32 |
| Corcept Therapeutics | 2 | $30 |
Products named: Cologuard Collection Kit, UBRELVY, Ozempic, NURTEC ODT, PREVNAR 20, ELIQUIS, QULIPTA, SHINGRIX.
Industry payments across PA — which companies pay providers there.
